中华传染病杂志
中華傳染病雜誌
중화전염병잡지
CHINESE JOURNAL OF INFECTIOUS DISEASES
2014年
8期
470-473
,共4页
李友炳%张军%陈靖%郑琦%董菁%朱月永%刘豫瑞%江家骥
李友炳%張軍%陳靖%鄭琦%董菁%硃月永%劉豫瑞%江傢驥
리우병%장군%진정%정기%동정%주월영%류예서%강가기
肝功能衰竭%磷%甲胎蛋白类%预后
肝功能衰竭%燐%甲胎蛋白類%預後
간공능쇠갈%린%갑태단백류%예후
Liver failure%Phosphorus%alpha-fetoproteins%Prognosis
目的 回顾性分析血清磷和甲胎蛋白(AFP)与肝功能衰竭患者病情和预后的关系.方法 收集202例肝功能衰竭患者的性别、年龄、AFP、国际标准化比值(INR)和生物化学指标.采用Spearman等级相关分析血清磷和AFP与血TBil、INR、白蛋白、ALT、肌酐的相关性.单因素Logistic回归分析血清磷和AFP与肝功能衰竭并发上消化道出血、肝性脑病、肺部感染和原发性细菌性腹膜炎的相关性;多因素Logistic回归分析肝功能衰竭患者4周内死亡的危险因素.结果 肝功能衰竭患者血清磷均值低于正常参考值,血清磷与TBil和AFP呈负相关(r值分别为-0.254、-0.271,均P<0.05),与血清肌酐呈正相关(r=0.312,P<0.05).AFP均值高于正常参考值,AFP与INR呈负相关(r=-0.159,P<0.05).血清磷和AFP与肝功能衰竭并发上消化道出血、肝性脑病、肺部感染和原发性细菌性腹膜炎无明显相关性.趋势分析显示,血清磷与终末期肝病模型(MELD)评分转归趋势有关(P<0.05),而AFP与MELD评分转归趋势无关(P>0.05);多因素Logistic回归分析显示,血清磷、AFP、MELD评分、上消化道出血、肝性脑病、肺部感染和原发性细菌性腹膜炎对死亡有影响.结论 血清磷和AFP与肝功能衰竭病情相关,是肝功能衰竭患者死亡的影响因素.
目的 迴顧性分析血清燐和甲胎蛋白(AFP)與肝功能衰竭患者病情和預後的關繫.方法 收集202例肝功能衰竭患者的性彆、年齡、AFP、國際標準化比值(INR)和生物化學指標.採用Spearman等級相關分析血清燐和AFP與血TBil、INR、白蛋白、ALT、肌酐的相關性.單因素Logistic迴歸分析血清燐和AFP與肝功能衰竭併髮上消化道齣血、肝性腦病、肺部感染和原髮性細菌性腹膜炎的相關性;多因素Logistic迴歸分析肝功能衰竭患者4週內死亡的危險因素.結果 肝功能衰竭患者血清燐均值低于正常參攷值,血清燐與TBil和AFP呈負相關(r值分彆為-0.254、-0.271,均P<0.05),與血清肌酐呈正相關(r=0.312,P<0.05).AFP均值高于正常參攷值,AFP與INR呈負相關(r=-0.159,P<0.05).血清燐和AFP與肝功能衰竭併髮上消化道齣血、肝性腦病、肺部感染和原髮性細菌性腹膜炎無明顯相關性.趨勢分析顯示,血清燐與終末期肝病模型(MELD)評分轉歸趨勢有關(P<0.05),而AFP與MELD評分轉歸趨勢無關(P>0.05);多因素Logistic迴歸分析顯示,血清燐、AFP、MELD評分、上消化道齣血、肝性腦病、肺部感染和原髮性細菌性腹膜炎對死亡有影響.結論 血清燐和AFP與肝功能衰竭病情相關,是肝功能衰竭患者死亡的影響因素.
목적 회고성분석혈청린화갑태단백(AFP)여간공능쇠갈환자병정화예후적관계.방법 수집202례간공능쇠갈환자적성별、년령、AFP、국제표준화비치(INR)화생물화학지표.채용Spearman등급상관분석혈청린화AFP여혈TBil、INR、백단백、ALT、기항적상관성.단인소Logistic회귀분석혈청린화AFP여간공능쇠갈병발상소화도출혈、간성뇌병、폐부감염화원발성세균성복막염적상관성;다인소Logistic회귀분석간공능쇠갈환자4주내사망적위험인소.결과 간공능쇠갈환자혈청린균치저우정상삼고치,혈청린여TBil화AFP정부상관(r치분별위-0.254、-0.271,균P<0.05),여혈청기항정정상관(r=0.312,P<0.05).AFP균치고우정상삼고치,AFP여INR정부상관(r=-0.159,P<0.05).혈청린화AFP여간공능쇠갈병발상소화도출혈、간성뇌병、폐부감염화원발성세균성복막염무명현상관성.추세분석현시,혈청린여종말기간병모형(MELD)평분전귀추세유관(P<0.05),이AFP여MELD평분전귀추세무관(P>0.05);다인소Logistic회귀분석현시,혈청린、AFP、MELD평분、상소화도출혈、간성뇌병、폐부감염화원발성세균성복막염대사망유영향.결론 혈청린화AFP여간공능쇠갈병정상관,시간공능쇠갈환자사망적영향인소.
Objective To retrospectively study the relationship between the serum level of phosphorus and α-fetoprotein (AFP) with the condition and prognosis of the patients with liver failure.Methods The sex,age,AFP,international normalized ratio (INR) and the biochemical indexes of 202 patients with liver failure were collected.The relationships of phosphorus and AFP with total bilirubin (TBil),INR,albumin,alanine aminotransferase (ALT) and creatinine (Cr) were analyzed by Spearman rank correlation.The relationships of phosphorus and AFP with liver failure complications including upper gastrointestinal bleeding,hepatic encephalopathy,pulmonary infection and primary bacterial peritonitis were analyzed by univariate Logistic regression.Multivariate Logistic regression was used to analyze the risk factors of 4-week death in patients with liver failure.Results The level of phosphorus in patients with liver failure was lower than the normal reference value.Serum level of phosphorus was both negatively correlated with TBil and AFP (r=-0.254,P<0.05; r=-0.271,P<0.05,respectively),but positively correlated with serum Cr (r=0.312,P<0.05).Conversely,the level of AFP in patients with liver failure was higher than the normal reference value and was negatively correlated with INR (r=-0.159,P< 0.05).Serum levels of phosphorus and AFP had no correlations with liver failure complications,such as upper gastrointestinal bleeding,hepatic encephalopathy,pulmonary infection and primary bacterial peritonitis.By trend analysis,phosphorus was associated with model for end-age liver disease (MELD) score (P<0.05).However,there was no association between AFP and MELD score (P>0.05).In addition,the analysis of multivariate Logistic regression showed that phosphorus,AFP,MELD,upper gastrointestinal bleeding,hepatic encephalopathy,pulmonary infection and primary bacterial peritonitis were associated with death of patients with liver failure.Conclusion Phosphorus and AFP are correlated with the outcome of patients with liver failure and are the risk factors of death in patients with liver failure.